Feng Lin1, Julie Suhr2, Stephanie Diebold3, Kathi L Heffner4. 1. School of Nursing, University of Rochester Medical Center, Rochester, NY 14642, USA; Department of Psychiatry, School of Medicine and Dentistry, University of Rochester Medical Center, Rochester, NY 14642, USA. Electronic address: vankee_lin@urmc.rochester.edu. 2. Department of Psychology, Ohio University, Athens, OH 45701, USA. 3. Texas Tech University Health Sciences Center, Amarillo, TX 79106, USA. 4. Department of Psychiatry, School of Medicine and Dentistry, University of Rochester Medical Center, Rochester, NY 14642, USA.
Abstract
OBJECTIVES: Accumulating evidence suggests an adverse association between depressive symptoms and cognition, but a positive association between insulin-like growth factor (IGF)-1 and cognition. The present study examined the influence of IGF-1 in the relationship between depressive symptoms and learning and memory. METHODS: A cross-sectional study of 94 healthy fit older adults. Blood was collected and plasma IGF-1 was measured. Depressive symptoms were assessed with the Geriatric Depression Scale (GDS), and learning and memory were assessed using the Rey Auditory Verbal Learning Test (AVLT). RESULTS: Among older adults with lower IGF-1 levels, higher depressive symptoms scores were associated with lower AVLT delayed recall and recognition. Older adults with higher IF-1 levels showed no associations between depressive symptoms and memory. CONCLUSIONS: The association between depressive symptoms and cognition is stronger among older adults with lower levels of circulating IGF-1. Further validation studies on groups with depression or different stages of cognitive impairment are needed. IGF-1 may be a novel intervention target for slowing cognitive decline in older adults with depressive symptoms.
OBJECTIVES: Accumulating evidence suggests an adverse association between depressive symptoms and cognition, but a positive association between insulin-like growth factor (IGF)-1 and cognition. The present study examined the influence of IGF-1 in the relationship between depressive symptoms and learning and memory. METHODS: A cross-sectional study of 94 healthy fit older adults. Blood was collected and plasma IGF-1 was measured. Depressive symptoms were assessed with the Geriatric Depression Scale (GDS), and learning and memory were assessed using the Rey Auditory Verbal Learning Test (AVLT). RESULTS: Among older adults with lower IGF-1 levels, higher depressive symptoms scores were associated with lower AVLT delayed recall and recognition. Older adults with higher IF-1 levels showed no associations between depressive symptoms and memory. CONCLUSIONS: The association between depressive symptoms and cognition is stronger among older adults with lower levels of circulating IGF-1. Further validation studies on groups with depression or different stages of cognitive impairment are needed. IGF-1 may be a novel intervention target for slowing cognitive decline in older adults with depressive symptoms.
Authors: Konrad Talbot; Hoau-Yan Wang; Hala Kazi; Li-Ying Han; Kalindi P Bakshi; Andres Stucky; Robert L Fuino; Krista R Kawaguchi; Andrew J Samoyedny; Robert S Wilson; Zoe Arvanitakis; Julie A Schneider; Bryan A Wolf; David A Bennett; John Q Trojanowski; Steven E Arnold Journal: J Clin Invest Date: 2012-04 Impact factor: 14.808
Authors: M Deuschle; W F Blum; C J Strasburger; U Schweiger; B Weber; A Körner; H Standhardt; U Gotthardt; J Schmider; C D Pflaum; I Heuser Journal: Psychoneuroendocrinology Date: 1997-10 Impact factor: 4.905
Authors: Kathi L Heffner; H Mei Ng; Julie A Suhr; Christopher R France; Gailen D Marshall; Wilfred R Pigeon; Jan A Moynihan Journal: Am J Geriatr Psychiatry Date: 2012-09 Impact factor: 4.105
Authors: William E Sonntag; Ferenc Deak; Nicole Ashpole; Peter Toth; Anna Csiszar; Willard Freeman; Zoltan Ungvari Journal: Front Aging Neurosci Date: 2013-07-02 Impact factor: 5.750
Authors: Ajaykumar N Sharma; Bruno Fernando Borges da Costa e Silva; Jair C Soares; André F Carvalho; Joao Quevedo Journal: J Affect Disord Date: 2016-03-02 Impact factor: 4.839
Authors: María Pedraz; Ana Isabel Martín-Velasco; Nuria García-Marchena; Pedro Araos; Antonia Serrano; Pablo Romero-Sanchiz; Juan Suárez; Estela Castilla-Ortega; Vicente Barrios; Rafael Campos-Cloute; Juan Jesús Ruiz; Marta Torrens; Julie Ann Chowen; Jesús Argente; Rafael de la Torre; Luis Javier Santín; María Ángeles Villanúa; Fernando Rodríguez de Fonseca; Francisco Javier Pavón Journal: PLoS One Date: 2015-03-03 Impact factor: 3.240
Authors: Nuria García-Marchena; Daniel Silva-Peña; Ana Isabel Martín-Velasco; María Ángeles Villanúa; Pedro Araos; María Pedraz; Rosa Maza-Quiroga; Pablo Romero-Sanchiz; Gabriel Rubio; Estela Castilla-Ortega; Juan Suárez; Fernando Rodríguez de Fonseca; Antonia Serrano; Francisco Javier Pavón Journal: PLoS One Date: 2017-11-06 Impact factor: 3.240